• Health

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 04, 2024 02:00 ET | Source: Verona Pharma plc Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October…